Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.

Andrew L Folpe, Kumarasen Cooper

Journal: Archives of pathology & laboratory medicine 2007;131(10):1517-24

PMID: 17922587

Free Full Text on Silverchair Information Systems View on PubMed

Abstract

CONTEXT

Pleomorphic cutaneous spindle cell tumors can be difficult to distinguish solely on histologic grounds. The use of ancillary immunohistochemical studies can greatly assist in this differential diagnosis.

OBJECTIVE

To review histologic and immunohistochemical aspects of cutaneous spindle cell tumors and discuss a basic panel of markers to assist in the differential diagnosis.

DATA SOURCES

English-language literature published between 1981 and 2005.

CONCLUSIONS

A basic immunohistochemistry panel for high-molecular-weight cytokeratin, melanocytic markers (S100 protein, HMB-45, Melan-A), smooth muscle actin, desmin, and endothelial markers (CD31, CD34) is effective in diagnosing most cutaneous spindle cell tumors.

Address: Division of Anatomic Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA. [email protected]

DOI: 10.5858/2007-131-1517-BPIDIP

Link outs

Free resources

Full Text Sources:

https://meridian.allenpress.com/aplm/article-looku...

Medical:

https://medlineplus.gov/skincancer.html

MeSH Terms: Biomarkers, Tumor, Carcinoma, Squamous Cell, Diagnosis, Differential, Histiocytoma, Malignant Fibrous, Humans, Immunohistochemistry, Melanoma, Sarcoma, Skin Neoplasms, Xanthomatosis